Company intelligence / Profile preview

Galenica

Ownership: Private
Employees: ~7000
Development stage: Commercial

Overview

Galenica is Switzerland’s leading fully integrated healthcare provider. It operates the country’s largest network of pharmacies—over 500 own, joint venture, and partner locations—and provides wholesale pharmaceutical distribution as well as health information services. The group also develops proprietary brands/products for the Swiss market but does not focus on novel drug R&D or clinical trials under its current structure.

Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Partnerships

collaborations with pharmaceutical manufacturers for distribution/logistics in SwitzerlandJV with Coop for pharmacy operations

Beyond the preview

Go deeper on Galenica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galenica.

Explore the full profile